Brochure | July 8, 2019

Capsugel® DBcaps® Brochure

Source: CapsugelĀ® | Lonza Pharma & Biotech

Capsugel® DBcaps® capsules are designed to eliminate patient bias in double blind clinical trials and ensure the highest patient compliance.

Advantages:

  • Eight different sizes of DBcaps® capsules are always in stock for double blinding a wide variety of comparator product shapes and sizes – no need to split, grind or alter your original dosage form
  • Active comparator products can be discreetly enclosed to improve patient compliance and tamper evident design prevent bias
  • Avoid concerns regarding alteration of the dosage form since there is no need to split or grind tablets
  • A long, established safety record means stability testing is kept to a minimum and bioequivalency testing may be reduced or eliminated

Download the brochure to learn more.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online